Share this page:

Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation (COAPT)

Phase: III
Status: Not Recruiting

The COAPT Trial is studying the MitraClip device in heart failure patients with functional mitral regurgitation to whom the local heart team will not offer mitral valve surgery as a treatment option. The trial compares the MitraClip device with no device in patients currently receiving optimal medical therapy.

Principal Investigator

Chad Rammohan, MD

Sponsor

Evalve, Inc, a subsidiary of Abbott Vascular

NCT Number

NCT01626079

Contact

Janet Lamm, Clinical Research Coordinator
Taft Center for Clinical Research
650-962-4566
Janet_Lamm@elcaminohealth.org

For more information about this clinical trial, including trial status, eligibility and full trial listing, visit www.clinicaltrials.gov.

You may also be interested in...

Visitor Screener

Visitor Restrictions

A visitor policy is in effect due to more restrictive measures being taken throughout the Bay Area.
HealthPerks Banner

Sign Up for HealthPerks

Get health information, event invitations, free screenings and more delivered to your inbox.
Find a doctor who will fit you well.

Find a Doctor

Use our directory to find a doctor with an office near our Mountain View or Los Gatos campus.